U.S. markets ended Tuesday's session in the red as the DJIA posted it's biggest one-day loss in more than a month. Shares of Vertex Pharmaceuticals (VRTX) spiked on Tuesday after the drug maker saw positive results from the phase 3 trials of its cystic fibrosis drug. Elizabeth Arden said it would cut jobs and discontinue some brands as it looks to streamline its operations. The Federal Reerve says it will give the four banks who failed the latest round of stress tests more time. Citigroup, HSBC, Santander USA and RBS Citizens will now get until January 5, 2015, to submit a new capital plan. Ruben Ramirez reports from Wall Street.

undefined

If you liked this article you might like

Vertex Pharmaceuticals Could Be Headed Higher Once Again

Omeros Shares Lower After Completing Stock Offering, Juno Dips - Biotech Movers

10 High-Yielding Stocks to Own Ahead of a Surprising Late Summer Market Swoon

Vertex Pharmaceuticals: Looking East, West and to the Quants

Vertex Pharmaceuticals: Looking East, West and to the Quants